Cc1cccc(-n2c(S)nnc2Cn2nc(C)c([N+](=O)[O-])c2C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?